Schizophrenia, ketamine and cannabis: evidence of overlapping memory deficits

[1]  A. Dickinson,et al.  Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis. , 2006, Archives of general psychiatry.

[2]  Edith Pomarol-Clotet,et al.  The Effects of a Subpsychotic Dose of Ketamine on Recognition and Source Memory for Agency: Implications for Pharmacological Modelling of Core Symptoms of Schizophrenia , 2006, Neuropsychopharmacology.

[3]  Clayton E. Curtis,et al.  Working memory functioning in schizophrenia patients and their first-degree relatives: cognitive functioning shedding light on etiology , 2005, Neuropsychologia.

[4]  A. Lahti,et al.  The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers , 2005, Psychopharmacology.

[5]  Mark Elliott,et al.  Levels-of-processing effect on frontotemporal function in schizophrenia during word encoding and recognition. , 2005, The American journal of psychiatry.

[6]  R. Henson.  A Mini-Review of fMRI Studies of Human Medial Temporal Lobe Activity Associated with Recognition Memory , 2005, The Quarterly journal of experimental psychology. B, Comparative and physiological psychology.

[7]  Kristen M. Haut,et al.  The Influence of Encoding Strategy on Episodic Memory and Cortical Activity in Schizophrenia , 2005, Biological Psychiatry.

[8]  Danielle C. Turner,et al.  Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task , 2005, Psychopharmacology.

[9]  E T Bullmore,et al.  Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. , 2005, Cerebral cortex.

[10]  S. Lal,et al.  Cognitive and clinical moderators of recognition memory in schizophrenia: a meta-analysis , 2005, Schizophrenia Research.

[11]  Ralitza Gueorguieva,et al.  Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction , 2005, Biological Psychiatry.

[12]  R. Astur,et al.  Selective Cognitive Impairments Associated with NMDA Receptor Blockade in Humans , 2005, Neuropsychopharmacology.

[13]  J. Gorman,et al.  A model of verbal memory impairments in schizophrenia: two systems and their associations with underlying cognitive processes and clinical symptoms , 2005, Psychological Medicine.

[14]  Georg Northoff,et al.  NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI , 2005, Schizophrenia Research.

[15]  D. Cyril D’Souza,et al.  Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects , 2005, Psychopharmacology.

[16]  C. Morgan,et al.  Long-term effects of ketamine: evidence for a persisting impairment of source memory in recreational users. , 2004, Drug and alcohol dependence.

[17]  Ralitza Gueorguieva,et al.  The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis , 2004, Neuropsychopharmacology.

[18]  Tyrone D. Cannon,et al.  Maintenance and manipulation of information in schizophrenia: further evidence for impairment in the central executive component of working memory , 2004, Schizophrenia Research.

[19]  E. Bullmore,et al.  Acute Ketamine Administration Alters the Brain Responses to Executive Demands in a Verbal Working Memory Task: an fMRI Study , 2004, Neuropsychopharmacology.

[20]  B. Stone,et al.  Effect of Δ-9-Tetrahydrocannabinol and Cannabidiol on Nocturnal Sleep and Early-Morning Behavior in Young Adults , 2004 .

[21]  B. Turetsky,et al.  Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. , 2004, The American journal of psychiatry.

[22]  Alan Gevins,et al.  Effects of marijuana on neurophysiological signals of working and episodic memory , 2004, Psychopharmacology.

[23]  J. Jentsch,et al.  A low dose of the alpha2 agonist clonidine ameliorates the visual attention and spatial working memory deficits produced by phencyclidine administration to rats , 2004, Psychopharmacology.

[24]  Anissa Abi-Dargham,et al.  Do we still believe in the dopamine hypothesis? New data bring new evidence. , 2004, The international journal of neuropsychopharmacology.

[25]  B. Brandner,et al.  Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers , 2004, Neuropsychopharmacology.

[26]  R. Gur,et al.  Levels-of-processing effect on word recognition in schizophrenia , 2003, Biological Psychiatry.

[27]  Danielle C. Turner,et al.  Subdissociative Dose Ketamine Produces a Deficit in Manipulation but not Maintenance of the Contents of Working Memory , 2003, Neuropsychopharmacology.

[28]  Stephan Felber,et al.  Neural correlates of episodic encoding and recognition of words in unmedicated patients during an acute episode of schizophrenia: a functional MRI study. , 2003, The American journal of psychiatry.

[29]  A. Baddeley.  Working memory: looking back and looking forward , 2003, Nature Reviews Neuroscience.

[30]  J. Kwon,et al.  N-Methyl-d-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  Philip D. Harvey,et al.  Cognition in schizophrenia: from basic science to clinical treatment , 2003, Psychopharmacology.

[32]  Lukas Scheef,et al.  Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. , 2003, The American journal of psychiatry.

[33]  J. Richards,et al.  Effects of THC on Behavioral Measures of Impulsivity in Humans , 2003, Neuropsychopharmacology.

[34]  M. Egan,et al.  Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. , 2003, The American journal of psychiatry.

[35]  D. Fujii,et al.  Neurocognition and community outcome in schizophrenia: long-term predictive validity , 2003, Schizophrenia Research.

[36]  Stephan Heckers,et al.  Impaired hippocampal recruitment during normal modulation of memory performance in schizophrenia , 2003, Biological Psychiatry.

[37]  E. Tulving.  Episodic memory: from mind to brain. , 2002, Annual review of psychology.

[38]  C. Brignell,et al.  Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users , 2002, Psychopharmacology.

[39]  N. I. Grinenko,et al.  Attenuation of Ketamine Effects by Nimodipine Pretreatment in Recovering Ethanol Dependent Men: Psychopharmacologic Implications of the Interaction of NMDA and L-Type Calcium Channel Antagonists , 2001, Neuropsychopharmacology.

[40]  C. Hart,et al.  Effects of Acute Smoked Marijuana on Complex Cognitive Performance , 2001, Neuropsychopharmacology.

[41]  A. Alavi,et al.  Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. , 2001, The American journal of psychiatry.

[42]  J. Cohen,et al.  Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. , 2001, The American journal of psychiatry.

[43]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Henson,et al.  Frontal lobes and human memory: insights from functional neuroimaging. , 2001, Brain : a journal of neurology.

[45]  D L Braff,et al.  Working memory in schizophrenia: transient "online" storage versus executive functioning. , 2001, Schizophrenia bulletin.

[46]  D. Javitt,et al.  Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. , 2000, Archives of general psychiatry.

[47]  P. Diemunsch,et al.  Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers , 2000, Psychopharmacology.

[48]  S. Rauch,et al.  Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance , 2000, Biological Psychiatry.

[49]  C. Morgan,et al.  Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. , 2000, Addiction.

[50]  A. Chan,et al.  Memory and organizational strategies in chronic and acute schizophrenic patients , 2000, Schizophrenia Research.

[51]  A. Belger,et al.  Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions , 2000, Biological Psychiatry.

[52]  D. Cyril D’Souza,et al.  Interactive effects of subanesthetic ketamine and haloperidol in healthy humans , 1999, Psychopharmacology.

[53]  Tamara Hershey,et al.  Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis , 1999, Neuropsychopharmacology.

[54]  S. Heishman,et al.  Acute and Residual Effects of Marijuana in Humans , 1998, Pharmacology Biochemistry and Behavior.

[55]  A. Malhotra,et al.  Effects of Ketamine on Thought Disorder, Working Memory, and Semantic Memory in Healthy Volunteers , 1998, Biological Psychiatry.

[56]  N. Alpert,et al.  Impaired recruitment of the hippocampus during conscious recollection in schizophrenia , 1998, Nature Neuroscience.

[57]  D. Cyril D’Souza,et al.  Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans , 1998, Psychopharmacology.

[58]  R. Roth,et al.  α‐noradrenergic receptor modulation of the phencyclidine‐ and Δ9‐tetrahydrocannabinol‐induced increases in dopamine utilization in rat prefrontal cortex , 1998 .

[59]  S. Heishman,et al.  Comparative Effects of Alcohol and Marijuana on Mood, Memory, and Performance , 1997, Pharmacology Biochemistry and Behavior.

[60]  R. Roth,et al.  Δ9-Tetrahydrocannabinol Increases Prefrontal Cortical Catecholaminergic Utilization and Impairs Spatial Working Memory in the Rat: Blockade of Dopaminergic Effects with HA966 , 1997, Neuropsychopharmacology.

[61]  J M Gorman,et al.  Mechanisms underlying memory impairment in schizophrenia , 1997, Psychological Medicine.

[62]  Herbert Weingartner,et al.  NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.

[63]  B. Moghaddam,et al.  NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[64]  T. Goldberg,et al.  Verbal working memory dysfunction in schizophrenia: use of a Brown-Peterson paradigm , 1995, Psychiatry Research.

[65]  M. B. Bowers,et al.  Regional brain catecholamines and metabolites following THC, PCP and MK-801 , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[66]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[67]  Z. Jocic,et al.  Memory and Frontal Lobe Dysfunction in Schizophrenia and Schizoaffective Disorder , 1993, The Journal of nervous and mental disease.

[68]  T. Goldberg,et al.  Forms of memory failure in schizophrenia. , 1992 .

[69]  R. Fields,et al.  Clonidine improves memory function in schizophrenia independently from change in psychosis Preliminary findings , 1988, Schizophrenia Research.

[70]  L. McClain.  Encoding and Retrieval in Schizophrenics' Free Recall , 1983, The Journal of nervous and mental disease.